Cathie Wood’s Alpha Tau Medical DRTS Stock Holding History

Cathie Wood’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.49M	Sell	277,086 -15,048	-5%	-$137K	0.02%	119
2026 Q1	$2.07M	Buy	+292,134	New	+$2.06M	0.02%	135

Other funds holding DRTS

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Cathie Wood's DRTS Position: Q2 2026 in Review

Cathie Wood reduced its Alpha Tau Medical (DRTS) stake by 5.2% in Q2 2026, selling an estimated $137K and leaving 277,086 shares worth $3.49M. The position accounts for 0.02% of the portfolio, ranked #119.

Cathie Wood first reported a position in DRTS in Q1 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

Cathie Wood held 277,086 shares of Alpha Tau Medical worth $3.49M as of Q2 2026.
Cathie Wood sold 15,048 Alpha Tau Medical shares in Q2 2026, an estimated $137K.
Alpha Tau Medical made up 0.02% of Cathie Wood's portfolio in Q2 2026, its #119 holding.
Cathie Wood first reported a position in Alpha Tau Medical in Q1 2026 and has held it in 2 quarters since.
74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on ARK Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.